Physician

Rashid Khan, M.D.

According to 2025 Medicare claims, Rashid Khan, M.D. (NPI: 1649446444) practices medical oncology in the South Bend-Mishawaka, IN-MI market, with the plurality of this provider's patient population coming from St. Joseph, IN. This provider's primary affiliated billing organization is MICHIANA HEMATOLOGY-ONCOLOGY P C (NPI: 1619970183; TIN: 351686054) and primary practice location at 46545-1470. Khan is affiliated with the CHA ACO, LLC (ACO ID: A2207), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 996 traditional Medicare patients, billed 153,772 HCPCS/CPT codes, and received $1,832,878 in Medicare payments. The top billing code was 74177 (Ct scan of abdomen and pelvis with contrast). Part D data shows 3,816 prescription claims across 621 beneficiaries totaling $8,944,323 in drug costs, led by Revlimid (Lenalidomide). DME data shows 16 claims. Open Payments data shows 37 records totaling $819. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $425,201 and ending at $1,832,878. Concurrently, Part D prescription costs have risen steadily, from $158,350 to $8,944,323. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,190 and ending at $871.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	293	28,555	$425,201
2016	688	188,532	$2,252,676
2017	773	281,686	$2,767,498
2018	940	323,733	$3,517,337
2019	983	328,321	$4,772,466
2020	736	113,680	$1,909,048
2021	673	76,386	$1,489,106
2022	982	172,087	$2,964,838
2023	1,007	229,282	$3,490,516
2024	996	153,772	$1,832,878

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	138	677	$158,350
2016	158	1,090	$810,573
2017	302	2,309	$3,385,119
2018	345	3,007	$5,683,741
2019	461	3,465	$6,263,302
2020	485	3,252	$5,562,495
2021	489	2,936	$5,549,023
2022	551	3,135	$5,652,133
2023	592	3,727	$7,755,171
2024	621	3,816	$8,944,323

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	113	$14,746
2018	22	155	$14,369
2019	N/R	93	$7,166
2020	N/R	51	$5,205
2021	N/R	64	$4,252
2022	N/R	38	$2,279
2023	N/R	70	$3,651
2024	N/R	16	$301

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
74177	Ct scan of abdomen and pelvis with contrast	113	128	$155
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	545	1,238	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	354	519	$61
71260	Ct scan of chest with contrast	125	144	$47
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	146	16,285	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	79	2,212	$1,399,700
Imbruvica	Ibrutinib	64	1,792	$1,034,049
Nubeqa	Darolutamide	56	1,680	$756,486
Brukinsa	Zanubrutinib	51	1,530	$662,697
Pomalyst	Pomalidomide	30	840	$641,880

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	16	$301

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$819	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rashid Khan, M.D.?

Tedicare shows public-source Medicare data for Rashid Khan, M.D. (NPI 1649446444), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rashid Khan, M.D. have ACO affiliation data?

Rashid Khan, M.D. is shown with ACO affiliation data for CHA ACO, LLC (MSSP, ACO ID A2207), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Rashid Khan, M.D.?

Rashid Khan, M.D. is linked to MICHIANA HEMATOLOGY-ONCOLOGY P C (billing NPI 1619970183) in the available physician profile data.

Does Rashid Khan, M.D. have Open Payments data?

Rashid Khan, M.D. has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.